Business Description
Vaxil Bio Ltd
NAICS : 325412
SIC : 3741
ISIN : CA92243L1076
Description
Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.9 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 46.4 | |||||
| 3-Year FCF Growth Rate | 30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 56.43 | |||||
| 12-1 Month Momentum % | 50.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10 | |||||
| Quick Ratio | 10 | |||||
| Cash Ratio | 6.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -15.81 | |||||
| ROA % | -14 | |||||
| ROIC % | -68.33 | |||||
| ROCE % | -16.66 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2 | |||||
| Price-to-Tangible-Book | 0.8 | |||||
| EV-to-EBIT | -3.28 | |||||
| EV-to-EBITDA | -3.28 | |||||
| EV-to-FCF | -2 | |||||
| Price-to-Net-Current-Asset-Value | 0.8 | |||||
| Earnings Yield (Greenblatt) % | -30.49 | |||||
| FCF Yield % | -16.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VXLLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vaxil Bio Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.006 | ||
| Beta | -0.63 | ||
| Volatility % | 211.55 | ||
| 14-Day RSI | 56.43 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.008 | ||
| 12-1 Month Momentum % | 50.94 | ||
| 52-Week Range ($) | 0.003 - 0.034 | ||
| Shares Outstanding (Mil) | 136.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vaxil Bio Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vaxil Bio Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vaxil Bio Ltd Frequently Asked Questions
What is Vaxil Bio Ltd(VXLLF)'s stock price today?
The current price of VXLLF is $0.01. The 52 week high of VXLLF is $0.03 and 52 week low is $0.00.
When is next earnings date of Vaxil Bio Ltd(VXLLF)?
The next earnings date of Vaxil Bio Ltd(VXLLF) is .
Does Vaxil Bio Ltd(VXLLF) pay dividends? If so, how much?
Vaxil Bio Ltd(VXLLF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers